Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)
Others
Ratios

Addex Therapeutics (ADXN) Interest & Investment Income: 2022-2024

Historic Interest & Investment Income for Addex Therapeutics (ADXN) over the last 3 years, with Dec 2024 value amounting to $19,880.

  • Addex Therapeutics' Interest & Investment Income rose 34.29% to $19,880 in Q4 2024 from the same period last year, while for Dec 2024 it was $31,270, marking a year-over-year decrease of 55.88%. This contributed to the annual value of $30,231 for FY2024, which is 57.55% down from last year.
  • Latest data reveals that Addex Therapeutics reported Interest & Investment Income of $19,880 as of Q4 2024, which was up 193.04% from -$21,368 recorded in Q3 2024.
  • In the past 5 years, Addex Therapeutics' Interest & Investment Income ranged from a high of $61,323 in Q1 2024 and a low of -$28,565 during Q2 2024.
  • Moreover, its 3-year median value for Interest & Investment Income was $14,825 (2023), whereas its average is $11,042.
  • In the last 5 years, Addex Therapeutics' Interest & Investment Income skyrocketed by 24,941.88% in 2023 and then tumbled by 292.40% in 2024.
  • Quarterly analysis of 3 years shows Addex Therapeutics' Interest & Investment Income stood at $26,311 in 2022, then slumped by 43.74% to $14,803 in 2023, then soared by 34.29% to $19,880 in 2024.
  • Its Interest & Investment Income stands at $19,880 for Q4 2024, versus -$21,368 for Q3 2024 and -$28,565 for Q2 2024.